The global antibiotic susceptibility testing market, valued at USD 2.82 billion in 2021, is anticipated to witness steady growth over the forecast period. Expanding at a Compound Annual Growth Rate (CAGR) of 5.2%, the market is projected to reach a valuation of USD 4.05 billion by 2028.
The rising prevalence of antibiotic-resistant infections worldwide is driving the demand for reliable susceptibility testing methods. These tests help determine the most effective antibiotics for treating infections, improving patient outcomes, and combating the growing threat of antimicrobial resistance (AMR).
Technological advancements in diagnostic tools, including automated testing systems and rapid diagnostic kits, are further boosting market expansion. Increased focus on precision medicine and stringent regulations promoting judicious antibiotic use are also contributing to the adoption of susceptibility testing across healthcare settings.
As global healthcare systems prioritize combating AMR, the antibiotic susceptibility testing market is set to play a crucial role in enabling effective infection management and safeguarding public health.
Key Growth Drivers
The growth of the antibiotic susceptibility testing market can be attributed to several factors:
- Increasing Incidence of Infectious Diseases: The rising occurrence of infections caused by antibiotic-resistant bacteria is driving the demand for effective susceptibility testing to guide treatment decisions.
- Growing Awareness of Antimicrobial Resistance (AMR): Increased awareness among healthcare professionals and the public regarding AMR has led to a greater emphasis on accurate diagnostic testing.
Market Dynamics
- The market includes various testing methods, such as disk diffusion, Etest, and automated systems, which are essential for determining the efficacy of antibiotics against specific pathogens.
- The adoption of automated systems is expected to grow rapidly due to their ability to provide faster and more accurate results compared to traditional methods.
Regional Insights
- North America is anticipated to hold the largest share of the antibiotic susceptibility testing market, driven by advanced healthcare infrastructure and significant investments in research and development.
- The Asia-Pacific region is expected to experience the fastest growth due to increasing healthcare needs and rising awareness about infection control measures.
Competitive Landscape
Leading market players have upgraded their manufacturing facilities and are engaged in a variety of R&D activities. Regulatory approvals, high-tech products, introduction of new products, acquisitions, and collaborative partnerships with other companies are all priorities for key providers of antibiotic susceptibility testing systems.
For instance,
- Alifax launched a ground-breaking proper system for rapid bacteria detection that gives antibiotic susceptibility and resistance testing in six hours and needs less manual labour, based on the rapid phenotyping method.
Key Companies Profiled
BD; Danaher; Thermo Fisher Scientific; Bio-Rad; Creative Diagnostics; Accelerate Diagnostics; Alifax; Roche Diagnostics Limited; Merck Group; Synbiosis; MP Biomedicals; QuantaMatrix Inc.; Resistell AG
Get the Comprehensive Full Report Now
Key Segments Of Antibiotic Susceptibility Testing Industry Survey
Antibiotic Susceptibility Testing Market by Product:
- Instruments
- Automated Broth Microdilution Systems
- Manual Broth Microdilution Systems
- Semi-automated Broth Microdilution Systems
- Software & Services
- Image & Analysis Software
- Installation Services
- Kits & Reagents
Antibiotic Susceptibility Testing Market by Application:
- Sepsis
- Respiratory Infections
- Gastrointestinal Infections
- Meningitis & Encephalitis
- Endocarditis
- Others
Antibiotic Susceptibility Testing Market by End User:
- Diagnostic Laboratories
- Hospitals
- Research Laboratories
Antibiotic Susceptibility Testing Market by Region:
- North America Antibiotic Susceptibility Testing Market
- Latin America Antibiotic Susceptibility Testing Market
- Europe Antibiotic Susceptibility Testing Market
- East Asia Antibiotic Susceptibility Testing Market
- South Asia & Pacific Antibiotic Susceptibility Testing Market
- Middle East & Africa (MEA) Antibiotic Susceptibility Testing Market
Author By:
Sabyasachi Ghosh (Associate Vice President at Future Market Insights, Inc.) holds over 12 years of experience in the Healthcare, Medical Devices, and Pharmaceutical industries. His curious and analytical nature helped him shape his career as a researcher.
Identifying key challenges faced by clients and devising robust, hypothesis-based solutions to empower them with strategic decision-making capabilities come naturally to him. His primary expertise lies in areas such as Market Entry and Expansion Strategy, Feasibility Studies, Competitive Intelligence, and Strategic Transformation.
Holding a degree in Microbiology, Sabyasachi has authored numerous publications and has been cited in journals, including The Journal of mHealth, ITN Online, and Spinal Surgery News.
About Future Market Insights (FMI)
Future Market Insights, Inc. (ESOMAR certified, recipient of the Stevie Award, and a member of the Greater New York Chamber of Commerce) offers profound insights into the driving factors that are boosting demand in the market. FMI stands as the leading global provider of market intelligence, advisory services, consulting, and events for the Packaging, Food and Beverage, Consumer Technology, Healthcare, Industrial, and Chemicals markets. With a vast team of over 400 analysts worldwide, FMI provides global, regional, and local expertise on diverse domains and industry trends across more than 110 countries.
Contact Us:
Future Market Insights Inc.
Christiana Corporate, 200 Continental Drive,
Suite 401, Newark, Delaware – 19713, USA
T: +1-347-918-3531
For Sales Enquiries: sales@futuremarketinsights.com
Website: https://www.futuremarketinsights.com
LinkedIn| Twitter| Blogs | YouTube